title: Lyme disease in central Europe.
abstract: Lyme borreliosis is a fascinating disease, the aetiopathology of which is not yet completely known. Different subspecies of Borrelia burgdorferi sensu lato are responsible for the variable clinical course of the disease. Some new cutaneous (alopecia) and ocular (photophobia and retinal vasculitis) manisfestations have been described and the largest prospective study on erythema migrans during pregnancy was published during the last year. Optimal therapy of Lyme borreliosis is still lacking, but doxycycline, amoxicillin, penicillin, and ceftriaxone are recommended most frequently.
authors.affiliation: Department of Dermatology and Venereology, Charles University, 2nd Medical School, Motol University Hospital, Prague, Czech Republic. jana.hercogova@lfmotol.cuni.cz
authors.forename: J
authors.initials: J
authors.lastname: Hercogova
authors.forename: I
authors.initials: I
authors.lastname: Brzonova
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D015748:Borrelia burgdorferi Group / Q000145:classification / Q000302:isolation & purification; D005060:Europe / Q000453:epidemiology; D006801:Humans; D008193:Lyme Disease / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology* / Q000503:physiopathology*
chemical_list: D000900:Anti-Bacterial Agents